Active Ingredient(s):Gefitinib FDA Approved: * May 5, 2003 Pharm Company: *ASTRAZENECA Category:Cancer
Gefitinib, sold under the brand name Iressa, is a medication used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR, but resistances to gefitinib can arise through other mutations. It is marketed by AstraZeneca and Teva.
It is on the World Health Organization's List of Essential Med...
* May have multiple approval dates, manufacturers, or labelers. 2 Discussions